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Abstract 
Background: Bacterial meningitis remains as a major cause of mortality and morbidity in many developing 
countries, including Ethiopia. Data on the type and antimicrobial resistance profile of the isolates from 
cerebrospinal fluid (CSF) is limited in Ethiopia and particularly in the study area. Therefore, the aim of this study 
was to identify bacterial pathogens from CSF and to determine their antimicrobial resistance profile at Felege 
Hiwot Referral Hospital (FHRH). 
Methods and Materials: A hospital-based cross-sectional study was conducted on 176 CSF samples collected 
from patients presumptive for meningitis at FHRH. Cerebrospinal fluid was collected by an experienced clinician 
aseptically and inoculated on blood, chocolate and MacConkey agars. Bacteriological culture and identification of 
the isolates was done following the conventional bacteriological procedure. Antimicrobial susceptibility testing 
(AST) was performed using the disk diffusion method. Data were entered and analyzed using Statistical Package 
for the Social Sciences (SPSS) version 23 for Windows. Descriptive statistics were used to present and summarize 
the findings.  
Results: Of the 176 study participants, 112 (63.6%) were males and 70 (39.8%) were infants. The mean age of the 
study participants was at 14.3 years. Eight (4.5%) CSF samples were found bacteriological culture positive. Of 
these, gram-negative isolates accounted for five cases (62.5%), including three E. coli, and one case each of K. 
pneumoniae and P. aeruginosa. The remaining three isolates were S. aureus. In this study, the overall multi-drug 
resistance (MDR) rate was at 75%. Gentamicin and ciprofloxacin were found effective against S. aureus. 
Similarly, gram-negative isolates were found sensitive to ceftazidime and ceftriaxone. 
Conclusions: In this study, the bacterial isolation rate from CSF was relatively low (4.5%). S. aureus, E. coli, K. 
pneumoniae and P. aeruginosa were identified and nearly one third of them were found to be multi-drug resistant 
which should be of concern to relevant stakeholders. A large-scale study is warranted. [Ethiop. J. Health Dev. 
2020; 34(1):14-21] 
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Introduction  
Bacterial meningitis (BM) is one of the most severe 
forms of infectious disease and a common cause of 
death and disability worldwide (1). BM affects 
approximately 1.2 million people each year and causes 
almost 170,000 deaths globally (2). The fatality rate is 
high, with a survival rate of between 2% and 30% (3). 
The highest burden of BM occurs in sub-Saharan 
Africa, known as the meningitis belt, which stretches 
from Senegal in the west to Ethiopia in the east (1). 
This area is characterized both by meningococcal 
hyperendemicity as well as by the intensity of its 
recurring epidemics, which affect close to 400 million 
people in 21 countries (4).  
 
The three main organisms that account for over 80% of 
the world’s cases of meningitis are Neisseria 
meningitidis, Streptococcus pneumoniae and 
Haemophilus influenzae type b (Hib) (5). Other 
pathogens that are associated with BM include L. 
monocytogenes, E. coli, K. pneumonia, Staphylococcus 
aureus, Streptococcus agalactiae, Streptococcus 
pyogenes, Salmonella spp., Pseudomonas aeruginosa, 
Entrobacter spp. and Acintobacter spp. (6,7). 
 
BM has for a long time been treated with a 
combination of penicillin/ampicillin and 
chloramphenicol, and this combination is still the 
widely recommended first choice in most of African 
countries. However, the increasing frequency of reports 
of bacterial resistance to these drugs has raised 
concerns that this choice may no longer be appropriate 
(8). Bacterial drug resistance is currently an emerging 
worldwide problem and a threat to public health, 
especially in developing countries including Ethiopia, 
because of the absence of well-equipped 
bacteriological laboratories and antimicrobial 
resistance surveillance activities (7). Antimicrobial 
resistance is changing over time and from place to 
place for different reasons. Because of the ever-
increasing number of drug-resistant strains over time, 
current information on local pathogens and their drug 
susceptibility profile is crucial for better management 
of patients and to monitor the onset of antimicrobial 
resistance (8-11). 
 
However, despite the challenges associated with BM in 
Ethiopia, particularly in the present study area, there is 
quite limited bacteriological data on the field. 
Therefore, this study was conducted to provide data on 
the bacteriology of CSF from patients presumptively 
diagnosed for meningitis.  
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Methods and Materials  
Study design, setting and period: A hospital-based 
cross-sectional study was conducted from 01 April to 
30 July 2018 at Felege Hiwot Referral Hospital 
(FHRH) located in Bahir Dar, which is situated about 
565km from Addis Ababa, the capital city. The 
hospital was established in 1952 and provides services 
in outpatient, inpatient and operation theatres for more 
than 10 million people in Bahir Dar city and the 
surrounding zones and regions.  
 
Population and sampling: Using a single population 
proportion formula at the prevalence of (4.3%), which 
was reported in Gondar (12), and a 95% confidence 
level (Z value at alpha 5%), with a margin of allowable 
error at 3%, our calculated sample size was at 176. We 
used a quota sampling technique in which the study 
populations were all patients presumptively diagnosed 
for meningitis that were visiting the hospital during the 
data collection period and willing to give CSF for 
bacteriological analysis. BM is hard to diagnose, as the 
signs and symptoms are frequently non-specific, 
particularly in young children. In our study, patients 
were presumptively diagnosed for meningitis when 
they were presented with a combination of the 
following symptoms: fever, poor feeding, vomiting, 
lethargy, and irritability. In older children, the extra 
typical signs of neck stiffness, headache and 
photophobia were also considered. Individuals who had 
taken antibiotics two weeks before the data collection 
period were excluded.  
 
Data collection 
Socio-demographic and clinical data collection: Data 
on socio-demographic characteristics of the 
participants – such as age, sex, residence, type of ward 
(outpatient, inpatient) – were collected using a 
structured questionnaire-guided interview. Moreover, 
laboratory-related data were collected on CSF culture 
and AST profile. 
 
CSF sample collection: The CSF samples were 
collected aseptically by an experienced clinician. After 
collection, samples were delivered to the bacteriology 
laboratory section of FHRH for analysis within 15 
minutes. A sterile wide-bore needle was inserted 
between the fourth and fifth lumbar vertebrae and the 
CSF (1ml-4ml) was allowed to drip into a dry sterile 
container. The volume and gross appearance of CSF 
(i.e. clearness, bloody or traumatic, cloudy and 
xanthochromic results) were recorded. For cloudy 
specimens, gram stain was done before centrifugation; 
if not, the CSF was centrifuged for gram stain. The 
CSF was centrifuged for 15 minutes at 2,500 to 3,000 
revolutions per minute when the volume was greater 
than 1ml (9, 5). 
 
CSF culture and isolate identification: All the CSF 
specimens were inoculated onto blood agar, chocolate 
agar and MacConkey agar. The blood and chocolate 
agar plates were incubated at 35-37°C in a candle jar 
with a capnophilic (5-10% CO2) environment. 
MacConkey agar was incubated aerobically and used 
for the isolation of gram-negative aerobic bacteria. 
Plates were examined for the presence of any bacterial 
growth after 18 to 24 hours incubation. Those plates 
showing no growth were incubated for another 24 
hours (9). Identification of the isolates was done based 
on the standard bacteriological techniques. Colony 
characteristics, gram reaction, and conventional 
different panel of biochemical tests were used to 
identify the isolates. These tests include catalase, 
coagulase and hemolytic activity on blood agar, for 
identification of gram-positive bacteria, while indole, 
citrate, triple sugar iron, urea, oxidase, and motility 
hydrogen sulphide gas production test panels were used 
to identify gram-negative bacteria (10,9). 
 
Antimicrobial susceptibility testing: Antimicrobial 
susceptibility testing was carried out using Kirby-
Bauer’s disk diffusion method on Mueller-Hinton agar, 
according to Clinical and Laboratory Standards 
Institute guidelines (11). About three to five pure 
colonies of each bacterium were picked using a sterile 
wire loop and emulsified into a tube containing 5ml of 
nutrient broth (Oxoid). The preparation was mixed 
thoroughly to make the suspension homogenous. 
  
The suspension of the identified test organism was 
prepared from similar colonies and the density of 
suspension was determined by comparing with 
McFarland 0.5 solutions in order to standardize the size 
of the inoculums. A sterile swab was dipped into the 
suspension and squeezed free from excess fluid against 
the side of test tube. Then, the surface of the Mueller-
Hinton agar plate was uniformly flooded with the 
suspensions and allowed to dry for about 15 minutes 
and the test organisms were uniformly seeded on the 
surface of the Mueller-Hinton agar and incubated at 
37°C for 18 to 24 hours (9). The diameters of the 
growth of inhibition were measured and interpreted 
according to the CLSI guidelines (11). 
 
The following antimicrobial discs were used based on 
the types of the bacterial isolates – for gram-negatives: 
ampicillin (AMP: 10 g), ceftazidime (CAZ: 30 g), 
ceftriaxone (CRO: 30 g), cefotaxime (CTX: 30 g), 
amoxicillin-clavulanate (AMC: 20/10μg) and 
piperacillin (PIP: 100 g) (specifically for P. 
aeruginosa); and for gram-positives: penicillin (P:10 
unit), clindamycin (DA: 2 g), cefoxitin (CXT: 30 g) 
and erythromycin (E: 15 g). For both groups of 
isolates, ciprofloxacin (CIP: 5 g), gentamicin (GEN: 
10 g), tetracycline (TE: 30 g), trimethoprim-
sulfamethoxazole (SXT: 1.25/23.75 g) and 
chloramphenicol (CAF: 30 g) were tested (11). 
 
Quality control: The reliability of the study findings 
was guaranteed by implementing quality control (QC) 
measures throughout the whole process of the 
laboratory work. The sterility of culture media was 
checked by incubating the batch at 35-37°C overnight 
and was evaluated for possible contamination. The 
standard reference bacteria strains, such as S. aureus 
(ATCC 25923), Pseudomonas aeruginosa (ATCC 
27853) and E. coli (ATCC 25922), were tested weekly 
as controls on the biochemical tests and agar plates, 
including Mueller-Hinton agar with antimicrobial 
discs, to assure testing performance of the potency of 
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antimicrobial discs. The data were double-checked for 
completeness and representativeness prior to entry. 
 
Data analysis: Data were entered and analyzed using 
SPSS version 23 for Windows. Descriptive statistics 
and data summary measures were used to present the 
data. The results were presented using tables and 
graphs. The distribution of the CSF culture result 
across the included variables was checked using Chi-
square test for statistical association. Significance was 
set at p-value <0.05. 
 
Ethical considerations 
Ethical clearance was approved by Bahir Dar 
University, College of Medicine and Health Sciences 
Institutional Review Board (IRB). Official letters of 
co-operation were provided to FHRH prior to data 
collection. Written informed consent (or assent) was 
obtained from study participants (or their 
parents/guardians) after explaining the purpose and 
objective of the study. Confidentiality was maintained 
and the laboratory results from the study participants 




Socio-demographic characteristics of the study 
participants: A total of 176 study participants were 
included in this study, of whom 112 (63.6%) were 
male, the mean age was at 14.3 years (range from 1 day 
to 68 years), 115 (65.3%) were from urban settings, 
and 76 (43.2%) were inpatients (Table 1).  
 
Table 1: Demographic characteristics of the study participants (n=176) attending FHRH from 
April to July 2018 
*NICU: neonatal intensive care unit 
 
Bacterial isolates among culture-positive CSF 
Of the 176 study participants, eight (4.5%) CSF 
samples had bacterial growth, of which five (62.5%) 
were gram-negative and three (37.5%) were gram-
positive (i.e. S. aureus). The gram-negative isolates 
were E. coli (n=3), K. pneumoniae (n=1) and P. 
aeruginosa (n=1).  
 
The distribution of the CSF culture result across the 
included variables does not show statistical association 
(p-value > 0.05). Details are presented in Table 2. 
 
Table 2: Cross-tabulation of CSF culture results with variables at FHRH from April to July 2018 
 CSF culture result   
Variables Total n (%) Positive n (%) Negative n 
(%) 
X2, p-value 
Age <28 days 14 (8) 1 (7.1) 13 (92.9) 2.36, 
0.501 28 days to 1 year 56 (31.8) 4 (7.1) 52 (92.9) 
1-15 years 43 (24.4) 2 (4.7) 41 (95.3) 
≥15 years 63 (35.8) 1 (1.6) 62 (98.4) 
Gender Male 112 (63.6) 6 (5.4) 106 (94.6) 0.5, 0.494 
Female 64 (36.4) 2 (3.1) 62 (96.9) 
Residence Rural 61 (34.7) 3 (4.9) 58 (95.1) 0.03, 
0.863 Urban 115 (65.3) 5 (4.3) 110 (95.7) 
Patient 
setting 
Inpatient 76 (43.2) 2 (2.6) 74 (97.4) 1.59, 
0.453 Outpatient 45 (25.6) 2 (4.4) 43 (95.6) 
NICU* 55 (31.2) 4 (7.3) 51 (92.7) 
Total 176 (100) 8 (4.5) 168 (95.5)  





Variables  Category N (%)  
 
Age  
<28 days 14 (8) 
28 days to 1 year 56 (31.8) 
1-15 years 43 (24.4) 
≥15 years 63 (35.8) 
Gender Male 112 (63.6) 
Female 64 (36.4) 
Residence Rural 61 (34.7) 
Urban 115 (65.3) 
Patient setting Inpatient 76 (43.2) 
Outpatient 45 (25.6) 
NICU* 55 (31.2) 
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Antimicrobial resistance profile of the isolates: Two 
of the three S. aureus isolates were found to be 
resistant to penicillin, cefoxitin, chloramphenicol and 
tetracycline. Similarly, almost all gram-negative 
bacteria isolated in this study were resistant to 
ampicillin. However, they were found to be sensitive to 
third-generation cephalosporins (ceftriaxone, 
cefotaxime and ceftazidime) and ciprofloxacin (Table 
3). 
 
In this study, six (75%) of the eight isolates were found 
to be multi-drug resistant (bacterial isolates that were 
found to be resistant to three or more classes of 
antibiotics). Two of the three S. aureus and four of the 
five gram-negative isolates were found to be multi-
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Number of resistance to antimicrobial agent, n  
PEN CXT CAF GEN ER SXT CIP TTC CL AMP CAZ PIP CRO AMC CTX 
S. aureus (n=3) 2 2 2 0 1 1 0 2 1 - - - - - - 
E. coli (n=3) - - 2 2 - 1 0 2 - 3 0 - 0 2 0 
K. pneumoniae 
(n=1) 
- - 1 1 - 1 1 1 - 1 0 - 0 1 0 
P. aeruginosa 
(n=1) 
- - - 1 - - 1 - - - 0 1 - - - 
 
Key: PEN: Penicillin; CXT: Cefoxitin; CAF: Chloramphenicol; GEN: Gentamicin; ER: Erythromycin; SXT: Trimethoprim-sulfamethoxazole; CIP:  
Ciprofloxacin; TTC: Tetracycline; CL: Clindamycin;  AMP: Ampicillin; CAZ: Ceftazidime; PIP: Piperacillin; CRO: Ceftriaxone; AMC: Amoxicillin-clavulanate; CTX: Cefotaxime. 
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Table 4: Multi-drug resistance (MDR) profile of bacterial isolates (n=8) from CSF at FHRH from 
April to July 2018 
Key: R0: Susceptible to all antibiotics; R1: Resistant to one antibiotic; R2: Resistant to two antibiotics; R3: 




For most Ethiopians, it is hard to get routine CSF 
culture and AST as part of routine patient management. 
Hence, in most cases, patients with a presumptive 
diagnosis for meningitis would normally be subjected 
to empirical therapies. Better practices, such as regular 
pathogen surveillance and AST profiling, are worth 
knowing about. In the present study, the types of 
bacterial isolates with their current AST profiles were 
described for patients presumptive for bacterial 
meningitis. 
 
A total of 176 study participants were included, of 
whom 112 (63.6%) were males. The mean age of the 
study participants was 14.3 years. In addition, about 70 
(39.8%) of the study participants were infants, 115 
(65.3%) lived in urban settings and 76 (43.2) were 
inpatients. The proportion of culture-positive CSF was 
4.5%. Similar findings were reported in Gondar, 
Ethiopia, at 4.3-5.6%, and in Nepal, at 4.5% 
(12,7,13,14).  However, our finding was lower than 
studies done in Namibia, Iran and India, which had 
CSF culture-positive proportions of 9.6%, 11.4% and 
19.1%, respectively (15–17). The reason for the low 
proportion in our study might be due to our limited 
sample size, and there might be clinical over-diagnosis 
of febrile patients for presumptive meningitis. On the 
other hand, the rate of bacterial isolation in our study is 
higher than other studies conducted in Nigeria, Iran and 
Gondar, Ethiopia, with isolation rates of 1.5%, 2.9% 
and 3.8%, respectively (18–20). This variation might 
be related to our sample size, or because of 
geographical or other socio-demographic variations. 
 
The predominant organisms isolated in this study were 
gram-negative, at five (62.5%). Different studies 
conducted in the field reported slightly different 
findings in this regard.  For example, Ogeneh and 
colleagues in Nigeria had a very similar finding to our 
result (18). In contrast, in studies done in Nepal, Iran, 
Namibia and Gondar, Ethiopia (15,17,12,7,14), the 
predominant isolated bacteria were gram-positive. 
Differences in sample size, study population, study 
design and geographical variation might explain the 
disparity. 
 
In this study, the type and frequency of identified 
isolates were: S. aureus (n=3), E. coli (n=3), K. 
pneumoniae (n=1) and P. aeruginosa (n=1). S. aureus 
and E. coli accounted for 75% of the isolates. Closely 
related findings were reported in Nigeria (18) as well 
as in Iran, where S. aureus/Coagulase-negative 
staphylococci (CONS) and E. coli were the common 
isolates from CSF (15). These observed differences 
could be attributed to several factors, such as 
underlying clinical conditions, virulence factors of the 
bacterial pathogens and the immune status of the 
patients. 
 
With regard to the AST profile, in our study we 
reported different resistance profiles of the isolates for 
different drugs they were tested for . Currently, 
pathogens with MDR are becoming a big challenge 
worldwide, especially in developing countries. The 
continued drug resistance arises for a number of 
reasons, such as a lack of well-organized bacteriology 
laboratories, poor health service set-up and irrational 
use of antimicrobials (7). 
In our study, the antimicrobial resistance level for S. 
aureus and gram-negative isolates ranged from 
between 0% to 100%. Six of the eight (75%)  isolates 
in this study were multi-drug resistant. Comparable 
findings at 50% to 62% were reported in Gondar, 
Ethiopia as well (13, 7). Multi-drug resistant, 
especially gram-negative, isolates were also reported in 
Iran identified from CSF sample (21). 
 
In our study, the most effective antibiotics against S. 
aureus were gentamicin and ciprofloxacin (100% 
sensitivity). This finding is comparable to the study 
conducted in Gondar, Ethiopia (7). However, two of 
the three S. aureus isolates showed the highest level of 
drug resistance against chloramphenicol, penicillin, and 
Organism 
isolated 







R1 R2 R3 R4 R5 R6 
E. coli (n=3) 0 1 0 0 1 1 0 2 
S. aureus (n=3) 1 0 0 1 0 0 1 2 
K. pneumoniae 
(n=1) 





0 1 0 0 0 1 
Total (n=8) 1 1 0 2 1 2 1 6 
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tetracycline. Dagnew et al.’s study in Gondar reported 
almost the same figure in this regard (7). 
 
Similarly, gram-negative isolates showed 100% 
sensitivity for cephalosporins, such as ceftazidime, 
cefotaxime and ceftriaxone. Similar findings were 
reported in Gondar, Ethiopia, and in Pakistan (12, 22). 
However, the study conducted in Iran showed that 
gram-negative bacteria were found to be resistant to 
cephalosporins (19,16). The variation could be due to 
geographical and antimicrobial usage policy 
differences.  
 
Similarly, in the present study, more than 80% of 
gram-negatives were resistant to ampicillin. Other 
studies conducted in Ethiopia and in Iran and Pakistan 
reported comparable findings (12, 23, 19, 22).  
 
Of the gram-negative isolates, E. coli showed 100% 
sensitivity for ceftazidime, ceftriaxone, and 
ciprofloxacin. Further, two of the three E. coli isolates 
showed relatively lower sensitivity for trimethoprim-
sulfamethoxazole. Other studies in Ethiopia and 
elsewhere in the world have also reported comparable 
findings (18, 12, 23). In contrast, all of the E. coli 
isolates showed resistance against ceftazidime, 
ceftriaxone and ciprofloxacin, according to a study 
conducted in Iran (24). 
 
Other gram-negative bacteria isolated in our study were 
K. pneumoniae, which was resistant to all antibiotics 
except cephalosporin. This finding is similar to the 
results of a study conducted in Addis Ababa, Ethiopia 
(23). Similarly, P. aeruginosa was found to be 
sensitive for ceftazidime, but resistant to piperacillin, 
gentamicin and ciprofloxacin, which is similar to the 
findings of studies conducted in Iran and Addis Ababa, 
Ethiopia (24, 23). In contrast to our study, a study 
conducted in India showed that P. aeruginosa was 
resistant to ceftazidime (16). 
 
In general, some differences reported from other 
studies in terms of the AST profile of the isolates might 
be attributed to the small sample size we employed and 
because of geographical and temporal differences. On 
top of this, differences in antibiotic prescription 
policies, the absence of guidelines regarding the 
selection of drugs, the social trend of inappropriate use 
of commonly prescribed drugs, and differences in 
infection prevention policy, resource and AST profiling 
capacity might contribute to different antimicrobial 
resistance reports around the globe. 
 
Using antibiotics without definitive diagnosis of 
specific pathogens leads to antimicrobial resistance of 
bacteria, which is currently an emerging worldwide 
problem that could be a great public health threat in 
developing countries such as Ethiopia. Because of the 
absence of well-equipped bacteriological laboratories 
in Ethiopia, there is no organized antimicrobial 
resistance surveillance system.  
 
Conclusions  
S. aureus, E. coli, K. pneumoniae and P. aeruginosa 
were the major pathogens isolated from culture-
positive CSF in this study. The frequency of MDR was 
75%. There is a need for periodic surveillance of the 
type of bacterial pathogens and their antimicrobial 
resistance profiles from CSF in the study setting. 
Further studies with a better design and a larger sample 
size should be conducted. 
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